1. Home
  2. GKOS vs COLB Comparison

GKOS vs COLB Comparison

Compare GKOS & COLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • COLB
  • Stock Information
  • Founded
  • GKOS 1998
  • COLB 1993
  • Country
  • GKOS United States
  • COLB United States
  • Employees
  • GKOS 995
  • COLB N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • COLB Major Banks
  • Sector
  • GKOS Health Care
  • COLB Finance
  • Exchange
  • GKOS Nasdaq
  • COLB Nasdaq
  • Market Cap
  • GKOS 5.1B
  • COLB 5.2B
  • IPO Year
  • GKOS 2015
  • COLB N/A
  • Fundamental
  • Price
  • GKOS $90.26
  • COLB $22.18
  • Analyst Decision
  • GKOS Strong Buy
  • COLB Hold
  • Analyst Count
  • GKOS 13
  • COLB 13
  • Target Price
  • GKOS $155.00
  • COLB $30.46
  • AVG Volume (30 Days)
  • GKOS 1.0M
  • COLB 1.8M
  • Earning Date
  • GKOS 04-30-2025
  • COLB 04-24-2025
  • Dividend Yield
  • GKOS N/A
  • COLB 6.50%
  • EPS Growth
  • GKOS N/A
  • COLB 43.26
  • EPS
  • GKOS N/A
  • COLB 2.55
  • Revenue
  • GKOS $383,481,000.00
  • COLB $1,823,444,000.00
  • Revenue This Year
  • GKOS $27.84
  • COLB $11.00
  • Revenue Next Year
  • GKOS $27.99
  • COLB $3.75
  • P/E Ratio
  • GKOS N/A
  • COLB $8.70
  • Revenue Growth
  • GKOS 21.85
  • COLB 2.22
  • 52 Week Low
  • GKOS $77.91
  • COLB $17.43
  • 52 Week High
  • GKOS $163.71
  • COLB $32.85
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 41.57
  • COLB 42.55
  • Support Level
  • GKOS $86.16
  • COLB $20.09
  • Resistance Level
  • GKOS $94.55
  • COLB $22.16
  • Average True Range (ATR)
  • GKOS 6.54
  • COLB 1.23
  • MACD
  • GKOS 1.11
  • COLB 0.03
  • Stochastic Oscillator
  • GKOS 54.51
  • COLB 46.47

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About COLB Columbia Banking System Inc.

Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.

Share on Social Networks: